Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam Tosilate vs midazolam + propofol for emergence agitation after non-cardiac thoracic surgery
ChiCTR2200055164Phase 4Recruiting
- Sponsor
- Shanghai Pulmonary Hospital
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in Emergence agitation (EA) (2 arms), sponsored by Shanghai Pulmonary Hospital. Primary endpoint: incidence of emergence agitation. Started Sep 2022; status: recruiting.
02
Drugs
remimazolam
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on ChiCTR2200055164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055164.